Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21
Phase 31

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator2
Other Roles3
PI Rate40%

Activity Timeline

Clinical Trials (5)

NCT04212351Completed
Frameshift Peptides of Children With NF1
Neurofibromatosis Type 1
PrincipalinvestigatorStart date: 2019-04-11
NCT00002875Phase 3Completed
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Brain TumorsCentral Nervous System Tumors
Studychair
NCT01158300Phase 1Completed
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Brain and Central Nervous System Tumors
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amar Gajjar, MD

St. Jude Children's Research Hospital

Moderately Similar
10 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsBrain NeoplasmsCentral Nervous System Neoplasms

Worked with same sponsors:

Children's Oncology GroupNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score34%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Related
12 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsBrain NeoplasmsCentral Nervous System Neoplasms

Worked with same sponsors:

Children's Oncology GroupNational Cancer Institute (NCI)
Similarity Score23%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neurofibromatosis 1Brain Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsBrain Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score8%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score8%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score8%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Brain and Central Nervous System Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score8%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04212351PrincipalInvestigator

Frameshift Peptides of Children With NF1

Neurofibromatosis Type 1
Completed
NCT00002875Phase 3StudyChair

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Brain TumorsCentral Nervous System Tumors
Completed
NCT00005602Phase 1StudyChair

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Brain and Central Nervous System Tumors
Completed
NCT00074334Phase 1/2StudyChair

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Brain and Central Nervous System Tumors
Terminated
NCT01158300Phase 1PrincipalInvestigator

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Brain and Central Nervous System Tumors
Completed

All 5 trials loaded